Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (341-350 of 520) with videos related to

Pageof 52
Sort By:
Cancer Research|April 15, 2010
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDFShadan Ali, Aamir Ahmad, Sanjeev Banerjee, et al.
Environmental Entomology|December 1, 2011
No unintended impacts of transgenic pine (Pinus radiata) trees on above ground invertebrate communitiesF-R Schnitzler, Elisabeth P J Burgess, Aliesha M Kean, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Cancer Research|October 6, 2005
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancerSanjeev Banerjee, Yuxiang Zhang, Shadan Ali, et al.
British Journal of Cancer|February 1, 1992
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideP A Philip, S Joel, S C Monkman, et al.
American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.
Indian Journal of Microbiology|July 4, 2012
Copper, Zinc-Superoxide Dismutase from Clinically Isolated Escherichia coli: Cloning, Analysis of sodC and Its Possible Role in PathogenicityM K Sanjay, S M Srideshikan, V L Vanishree, et al.
Journal of Gynecology Obstetrics and Human Reproduction|May 15, 2023
Surgical management of a loss of pregnancy in the first trimester: Patient experience and influencing factors, a prospective observational studyT Toutain, C-A Philip, L Bollon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.
Pageof 52

Showing results (341-350 of 520) with videos related to

Sort By:
Pageof 52
Cancer Research|April 15, 2010
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDFShadan Ali, Aamir Ahmad, Sanjeev Banerjee, et al.
Environmental Entomology|December 1, 2011
No unintended impacts of transgenic pine (Pinus radiata) trees on above ground invertebrate communitiesF-R Schnitzler, Elisabeth P J Burgess, Aliesha M Kean, et al.
Small Gtpases|June 23, 2017
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferationRamzi M Mohammad, Yiwei Li, Irfana Muqbil, et al.
Cancer Research|October 6, 2005
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancerSanjeev Banerjee, Yuxiang Zhang, Shadan Ali, et al.
British Journal of Cancer|February 1, 1992
A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposideP A Philip, S Joel, S C Monkman, et al.
American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.
Indian Journal of Microbiology|July 4, 2012
Copper, Zinc-Superoxide Dismutase from Clinically Isolated Escherichia coli: Cloning, Analysis of sodC and Its Possible Role in PathogenicityM K Sanjay, S M Srideshikan, V L Vanishree, et al.
Journal of Gynecology Obstetrics and Human Reproduction|May 15, 2023
Surgical management of a loss of pregnancy in the first trimester: Patient experience and influencing factors, a prospective observational studyT Toutain, C-A Philip, L Bollon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I study of intravenous 4-hydroxyanisoleG J Rustin, M R Stratford, A Lamont, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.
Pageof 52